Note to users. If you're seeing this message, it means that your browser cannot find this page's style/presentation instructions -- or possibly that you are using a browser that does not support current Web standards. Find out more about why this message is appearing, and what you can do to make your experience of our site the best it can be.

Site Tools

  • AAAS
  • Subscribe
  • Feedback

Site Search

Search Advanced

Science 12 December 1997:
Vol. 278. no. 5345, p. 1874
DOI: 10.1126/science.278.5345.1874
Prev | Table of Contents | Next

News & Comment

BIOTECHNOLOGY PATENTS:
The Battle Over BRCA1 Goes to Court; BRCA2 May Be Next

Eliot Marshall

What began a decade ago as a race to find the genes that increase a woman's risk for breast cancer (BRCA1 and BRCA2) has evolved into a bitter court battle over who owns the right to exploit these genes commercially. Over the past month, two U.S. genetic testing companies have sued each other for patent violations. The legal jousting once again raises questions about the value of gene patents and threatens to stir up old grievances in the field.

Read the Full Text


THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES:
Watching the Race to Find the Breast Cancer Genes.
R. Dalpe, L. Bouchard, A.-J. Houle, and L. Bedard (2003)
Science Technology Human Values 28, 187-216
   Abstract »    PDF »


ADVERTISEMENT
Click Me!

ADVERTISEMENT
Click Me!

To Advertise     Find Products

Science. ISSN 0036-8075 (print), 1095-9203 (online)